Letter to APBD Community

Dear Friend, In the May 2025 newsletter, we highlight two powerful examples of momentum in research and advocacy.  First, we explore the groundbreaking personalized treatment advances led by the n-Lorem Foundation. Although this therapy (which is still in development) [Read More]

May 23rd, 2025|

Navigating a Presymptomatic Diagnosis

By Liv Palma May 22, 2025 What is a presymptomatic diagnosis? Due to the increased availability of genetic testing, including carrier screening, several members of our community have received a genetic, but presymptomatic, diagnosis of APBD. That is, they [Read More]

May 23rd, 2025|

Q&A with Or Kakhlon, PhD

Dr. Or Kakhlon is an associate professor in the Department of Neurology at Hadassah-Hebrew University Medical Center and a long-standing member of the APBD Research Foundation’s Scientific Advisory Board. He has been an important contributor to APBD research, co-authoring [Read More]

December 14th, 2024|

Patient Perspectives Shared with the FDA

The APBD Research Foundation recently participated in the FDA’s Listening Session on “Patient and Care Partner Perspectives on Early Enrollment into Gene Therapy Clinical Trials for Rare Diseases.” Becca Reef, MS, CGC, our Scientific Coordinator, spoke on [Read More]

December 13th, 2024|
Go to Top